Immunogenic peptides from the HPV E7 protein
First Claim
Patent Images
1. A nucleic acid comprising a coding sequence coding for expression of a peptide less than 19 amino acids in length, wherein the peptide comprises the amino acid sequence Leu Met Gly Thr Leu Gly Ile Val Cys Pro Ile Cys (SEQ ID NO:
- 16).
5 Assignments
0 Petitions
Accused Products
Abstract
The invention provides immunogenic peptides from the HPV type 16 E7 protein that comprise overlapping class I restricted T cell epitopes. Also disclosed are methods of administering DNA molecules encoding these peptides to a host mammal.
-
Citations
35 Claims
- 1. A nucleic acid comprising a coding sequence coding for expression of a peptide less than 19 amino acids in length, wherein the peptide comprises the amino acid sequence Leu Met Gly Thr Leu Gly Ile Val Cys Pro Ile Cys (SEQ ID NO:
- 9. A nucleic acid comprising a coding sequence coding for expression of a polypeptide comprising a first peptide and a second peptide linked by a peptide bond, the first peptide comprising a trafficking sequence, and the second peptide consisting of a sequence 12-18 amino acids in length comprising the sequence Leu Met Gly Thr Leu Gly Ile Val Cys Pro Ile Cys (SEQ ID NO:
-
31. A DNA comprising the sequence of SEQ ID NO:
- 5.
-
32. A DNA comprising the sequence of nucleotides 3219-3624 of SEQ ID NO:
- 7.
-
33. A DNA comprising the sequence of nucleotides 3290-3413 of SEQ ID NO:
- 7.
-
34. A plasmid DNA comprising the sequence of SEQ ID NO:
- 7.
-
35. A microparticle comprising a polymeric matrix and a nucleic acid, wherein the polymeric matrix consists essentially of poly-lactic-co-glycolic acid (PLGA) and the nucleic acid comprises the sequence of SEQ ID NO:
- 7.
Specification